Our previous genome-wide association study (GWAS) in a Hong Kong Southern Chinese population with extreme bone mineral density (BMD) scores revealed suggestive association with MPP7, which ranked second after JAG1 as a candidate gene for BMD. To follow-up this suggestive signal, we replicated the top singlenucleotide polymorphism rs4317882 of MPP7 in three additional independent Asian-descent samples (n 5 2684). The association of rs4317882 reached the genome-wide significance in the meta-analysis of all available subjects (P meta 5 4.58 3 10 28 , n 5 4204). Site heterogeneity was observed, with a larger effect on spine than hip BMD. Further functional studies in a zebrafish model revealed that vertebral bone mass was lower in an mpp7 knock-down model compared with the wide-type (P 5 9.64 3 10 24 , n 5 21). In addition, MPP7 was found to have constitutive expression in human bone-derived cells during osteogenesis. Immunostaining of murine MC3T3-E1 cells revealed that the Mpp7 protein is localized in the plasma membrane and intracytoplasmic compartment of osteoblasts. In an assessment of the function of identified variants, an electrophoretic mobility shift assay demonstrated the binding of transcriptional factor GATA2 to the risk allele 'A' but not the 'G' allele of rs4317882. An mRNA expression study in human peripheral blood mononuclear cells confirmed that the low BMD-related allele 'A' of rs4317882 was associated with lower MPP7 expression (P 5 9.07 3 10 23 , n 5 135). Our data suggest a genetic and functional association of MPP7 with BMD variation.
INTRODUCTION
Osteoporosis is a common skeletal disorder characterized by compromised bone strength that leads to an increased risk of fracture. Bone mineral density (BMD) accounts for 70% of the variance in bone strength and is an important clinical predictor of fracture. Genetic factors have been shown to be responsible for 50-80% of the variance of BMD (1, 2) . Since 2007, several genome-wide association studies (GWAS) on BMD variation were reported. Some well-known or novel loci to osteoporosis were identified and confirmed with a very strong statistical support (2, 3) . Nevertheless, all the identified variants to date have modest effect size and together account for only a small fraction of the variance in liability to osteoporosis. Many more associated loci of osteoporosis therefore remain to be discovered. There may be some lower-ranked single-nucleotide polymorphisms (SNPs) that are also true variants for osteoporosis without reaching genome-wide significance, because their effect size is too small to achieve adequate statistical power, given the sample sizes of GWAS to date. Analysis of the lower-ranked signals by follow-up studies may uncover further variants that truly contribute to BMD variation.
Our group initiated a GWAS of BMD in 800 female Hong Kong Southern Chinese (HKSC) subjects with extreme BMD (4) . The study strongly supported the JAG1 gene as a candidate for BMD regulation and a potential key factor for fracture pathogenesis. Suggestive association was identified in the MPP7 gene in the GWAS discovery phase. MPP7 was further replicated and ranked as the second signal in our firststep replication study, although it failed to reach genome-wide significance in the second replication stage (P ¼ 1.74 × 10
26
, n ¼ 1520). In this study, to further follow-up this suggestive signal, we first investigated the association of MPP7 with BMD via genotype imputation. Subsequently, we conducted further association analyses of the top MPP7 allele in three additional independent Asian-descent samples. Finally, we conducted functional study on the MPP7 gene and its putative risk variant.
RESULTS

Imputation analysis of MPP7 using HapMap
Quality-control checks, as detailed in Kung et al. (4) , led to the exclusion of 15 subjects. GWAS genotype data of 785 subjects, in the MPP7 region, were used in the analysis. Imputation was performed to achieve a more comprehensive coverage of the MPP7 gene and its flanking (2 kb) regions. SNPs that were not genotyped but were presented in the HapMap Phase II (5) Asian data were imputed for the 785 subjects. A total of 55 genotyped SNPs and 251 imputed SNPs with imputation quality score ≥0.4 were used for the association analysis.
A regional plot of the association results ( Fig. 1) shows that SNP rs4317882 has the strongest association with BMD in the MPP7 gene, which was among the suggestive variants identified in the HKSC discovery cohort and replicated in the firststep replication cohort (Table 1) . We then conducted the further association analyses conditional on rs4317882 in our discovery cohort to determine whether there could be more than one independent association signals in the MPP7 gene. There was no other variant in the studied region that showed significant association with BMD variation after adjusting for the observed association of rs4317882. All of the variants with a P-value ,1 × 10 24 were in high linkage disequilibrium (LD) with rs4317882 (r 2 . 0.5). Therefore, only SNP rs4317882 was selected for the follow-up replication studies.
Replication study
Subsequently, we genotyped rs4317882 in three other independent northern Chinese samples to verify its association with BMD. Supplementary Material, Table S1 showed the characteristics of studied populations. As shown in Table 1 , two of them (SH1 and BJ3 groups) successfully validated the association of rs4317882 with low BMD (P one-side , 0.05) at the lumbar spine (LS), and the SH2 group had a marginal significance (P one-side ¼ 0.06), which could be because of the small number of subjects (n ¼ 613). All of them showed the same direction of effect with the HKSC discovery and fist-step replication cohorts, with the 'A' allele being associated with low BMD. The meta-analysis in all subjects from the HKSC discovery cohort, fist-step replication cohort and the three northern Chinese samples supported the association between rs4317882 and LS BMD with the P-value reaching genome-wide significance (P meta ¼ 4.58 × 10
28
). SNP rs4317882 is located in the intron 7 of MPP7. These results strongly implicate MPP7 as a candidate gene for BMD variation.
In addition, we identified the site-specific effect of rs4317882 in MPP7 on LS BMD. Its association with FN BMD in the fist-step replication cohort and all three northern Chinese replication samples was not significant (P . 0.05, Table 1 ); heterogeneity test showed that its effect on BMD was significantly stronger at LS than at FN (P het , 0.05). Figure 1 . Association plot of MPP7 gene variants with LS BMD in HKSC discovery cohort using the imputation data based on HapMap (Phase II R22 release). X-axis: the genomic position (B36); Y-axis: the 2log 10 (P-value) of association results (left scale) and the fine-scale recombination rate (B36, right scale); diamond, the top SNP, i.e. rs4317882. The colors of dots are coded according to the degree of linkage disequilibrium (r 2 ) with the top SNP rs4317882.
The allelic variance of rs4317882 accounted for 0.5% of BMD variance at LS in the studied samples.
We also sought to validate the findings of this study via publicly available in silico GWAS data, i.e. the deCODE Genetics Study, of LS and FN BMD (6) . There is no information of rs4317882 in this publicly available data. This SNP has very low frequency of the risk allele 'A' (,0.05) in the Europeandescent population compared with an Asian-descent population where it is very common (.0.40). SNP rs9299597 is the top variant (P ¼ 1.82 × 10
23
) for LS BMD in this European-descent population, and there was no variant that shows association with BMD at FN. SNP rs9299597 was not associated with BMD in our discovery data (P . 0.1) and it had a low LD with rs4317882 (r 2 , 0.25) in both ethnic groups. The frequency of the 'G' allele of rs9299597 is 0.90 in the European-descent population and 0.15 in the Asian-descent population. These results may suggest the existence of allelic heterogeneity of the MPP7 gene in different ethnic groups. MPP7 is supported as a candidate gene for LS BMD in both Asian-and European-descent populations through the same or different causal variants. Further studies are required to dissect this allelic heterogeneity, which may be important when understanding the relationship between the MPP7 gene and BMD in different ethnicities.
Fine-mapping with 1000 Genome data
Recently, the 1000 Genomes Project (7) data with much higher density of common and lower frequency variants in the genomic region has become available, compared with the HapMap data which primarily includes variants with minor allele frequency (MAF) .5%. To explore whether stronger, true association signals were not captured by the common genotyped and imputed variants from the HapMap data, we imputed and captured 994 of the 1327 polymorphic variants observed from the Asian data of 1000 Genome Phase I interim release in our GWAS discovery subjects with imputation quality score ≥0.4. Data on 772 common variants (MAF . 5%) and 222 variants with MAF in the range 00.0-0.05 are available. Approximately 680 additional SNPs were previously not captured by imputation from HapMap. As shown in Supplementary Material, Figure S1 , despite testing many additional variants at a wide range of allele frequencies, we failed to find an association signal that was stronger than rs4317882. Although our sample size might have limited power to achieve the maximum association signal for lower-frequency SNPs, no additional variant showed an independent association signal with BMD according to the conditional analysis on rs4317882. Next, we predicted the potential function of rs4317882 and SNPs in high LD with rs4317882 (r 2 ≥ 0.8) in the Asian-descent population and SNPs in high LD with rs9299597 (r 2 ≥ 0.8) in the European-descent population using the FASTSNP program (8) . These SNPs were all located in the intronic region, with some of them with potential regulating function on the mRNA expression or splicing (Supplementary Material, Table S2 ).
Sequencing of MPP7 coding region
To determine whether there were any other unobserved variants that could be the causal variants, we sequenced the coding region and their 500 bp flanking genomic sequence of MPP7 gene, in 25 high-BMD and 25 low-BMD HKSC subjects carrying the variant allele of rs4317882. This sequencing effort identified a novel polymorphism in exon 5 with a change of 'G' to 'T' (29Val/Val). Further genotyping of this synonymous polymorphism in all of the 1520 HKSC subjects with extreme BMD revealed an extremely low frequency of the 'T' allele (3.3 × 10
24
).
Reduction of bone mass in mpp7 knock-down zebrafish
We used the zebrafish model to study the potential function of MPP7 gene in bone metabolism. Previous study in zebrafish demonstrated that mutations of the mpp7 gene could lead to humpback of the body shape of larvae and malformed and ankylotic vertebrae in adult fish. No morphological differences from the wild-type (wt), apart from the bent longitudinal body axis, were detected at stages of development prior to the appearance of bone defects (9) . To study the influence of mpp7 on bone metabolism and BMD, we compared bone mass among the zebrafish wt, mpp7 knock-down (mpp7 MO ) and rescued (mpp7 MO + mpp7 mRNA) groups. The number of normal and humpback zebrafish in each group was shown in Supplementary Material, Table S3 . About 77% of The discovery and first-step replication cohorts with extreme BMD used in the GWAS study (4) . b Estimated b was calculated for cohorts with extreme BMD based on the DeMets-Halperin formula.
c
The one-sided P-values are listed in the replication cohorts, as they have the same direction of effect with the initial discovery phase.
mpp7
MO embryos showed a typical ventral bending of the tail that appeared 24 hour-post-fertilization (hpf), the time when the developing tail should normally be straight ( Fig. 2A -C) . Affected zebrafish could only swim in tight circles. The percentage of humpback phenotype in the mpp7 MO group was evidently higher than in the wt group (P ¼ 1.90 × 10 210 , n ¼ 79). Furthermore, bone mineralization was affected in mpp7 MO zebrafish ( Fig. 2D -K). The relative bone mass, quantified by measuring the fluorescent intensity of the alizarin red stain in vertebrae 3 -5 and normalized to the wt zebrafish, was significantly lower in mpp7 MO than in wt zebrafish (P ¼ 9.64 × 10
24
, n ¼ 21, Fig. 2K ). Rescue of mpp7
MO zebrafish by addition of mpp7 mRNA could partially reverse the bent tail phenotype and increase bone mass (Supplementary Material, Table S3 and Fig. 2K ).
Functionality of MPP7 in osteoblasts
We studied the mRNA expression of MPP7 gene in human bone-derived cells (HBDCs) which were undergoing osteogenesis. MPP7 was constitutively expressed in HBDCs during proliferation and differentiation phases (Fig. 3A) , and the quantitative real-time polymerase chain reaction (qRT-PCR) study demonstrated the increased expression of MPP7 in the later stage of differentiation (Supplementary Material, Fig. S2 ). Furthermore, expression of Mpp7 protein in osteoblasts by immunofluorescent technique in the murine MC3T3-E1 cell (Fig. 3B) localized the protein to the plasma membrane and intracytoplasmic compartment. In addition, transient knock-down of Mpp7 in MC3T3-E1 cells did not change the gene expression of Runx2 and Osterix, the two master factors that control osteoblast differentiation (data not shown). These results suggest that MPP7 is important during the differentiation of osteoblasts but might not via RUNX2 or OSTERIX pathways.
Association of rs4317882 genotype and MPP7 mRNA expression SNP rs4317882 had the strongest association with BMD in this study. We further documented a significant relation between rs4317882 genotype and mRNA expression of MPP7 in human peripheral blood mononuclear cells (PBMCs) using qRT-PCR. The low-BMD-related 'A' allele showed a significant association with low mRNA expression of MPP7 gene in PBMCs (P ¼ 9.07 × 10
23
, n ¼ 135, Fig. 3C ). Subjects with AA genotype had 2-fold lower expression levels than subjects with GG genotype. We next searched the eQTL Browser (10) and mRNA by SNP Browser (11), but none of the 14 publicly available databases had eQTL in the MPP7 gene region. This could be due to a difference in studied tissue types and disease populations, and eQTL study in human bone cells would provide more direct information on pathogenesis of osteoporosis. In addition, as rs4317882 lies in intron 7 and intronic sequence variation might affect mRNA splicing, we studied the mRNA species from HBDCs of subjects with different rs4317882 genotypes. Different variations in mRNA species were observed, but they resulted from the known splicing site that is not related to rs4317882, according to the sequencing data (data not shown).
Generation of GATA2 binding site in the variant allele of rs4317882
Furthermore, the bioinformatics analysis suggested that the allele change (G/A) at rs4317882 could generate a binding site of GATA family transcription factors, i.e. GATA1 and GATA2, or demolish a binding site of deltaE transcription binding factor. The three predicted transcription factors were therefore tested using the electrophoretic mobility shift assay (EMSA) to validate their potential changes of binding to MPP7 caused by rs4317882.
The results indicated that the G/A change at rs4317882 could generate a binding site in the MPP7 gene for GATA2 [MIM 137295] (Fig. 4) , and there is no binding site for GATA1 and deltaE transcription factor (data not shown). We found a strong and specific binding of the nuclear extract of HEK293 cells transfected with pCMV-GATA2 to the probe with the rs4317882 risk allele 'A' (Fig. 4, lane 3) . It also showed a relatively weaker band resulting from the binding between the probe with the 'A' allele and the endogenous GATA2 from HEK293 untreated that is without the transfection of the pCMV-GATA2 construct (Fig. 4, lane  2) . No binding of the nuclear extract to the probe containing the major allele 'G' of rs4317882 was observed (Fig. 4,  lanes 7 and 8) . Binding to the probe with the 'A' allele was specifically competed by 660-fold excess of unlabeled probe with the 'A' allele (Fig. 4, lane 4) . The binding specificity was confirmed by the supershift assay, in which one DNAprotein complex was supershifted by the addition of the GATA2 antibody (Fig. 4, lane 5) .
DISCUSSION
In this study, we identified the MPP7 gene as a candidate gene for LS BMD. MPP7 gene is the second-ranked gene with suggestive association to BMD variation in our previous GWAS (4). To follow-up this suggestive signal, the identified, most significant variant rs4317882 in the MPP7 gene was successfully replicated in three independent Asian-descent samples and further reached the genome-wide significance in the meta-analysis (P meta , 5.00 × 10
28
). Evidence from publicly available in silico GWAS data in an European-descent population supported that MPP7 is a candidate gene for BMD at the spine, although the risk attributable to MPP7 may differ from Asian-descent population as the LD between the two top SNPs in the two ethnic groups is low (r 2 , 0.25). Our finding on MPP7 is supported by the meta-analysis conducted by the Genetic Factors for Osteoporosis Consortium. The data derived from 16 European-descent populations and our southern Chinese population revealed a significant association of MPP7 with a stronger effect on LS BMD (12) . Fine mapping of additional, common and low-frequency SNPs from 1000 Genome data showed no other stronger or independent association signal. Nonetheless, despite this comprehensive imputation and exon sequencing, our study cannot exclude the possibility that the two top SNPs may be in LD with an untested causative variant. Three hundred and thirtythree out of 1327 polymorphic variants from the 1000 Genome data cannot be captured in this study using imputation, of which 99% are variants with MAF , 5%. The increasing tag density in GWAS samples and improved imputation methods may be required to fully exploit the 1000 Genome data in future (13) . The existence of allelic heterogeneity has been identified for human complex diseases including osteoporosis (14-16). Paternoster et al. (15) recently reported allelic heterogeneity at the well-known osteoporosis-related RANKL locus that could have two independent causal variants influencing the cortical BMD. The understanding of allelic heterogeneity in disease-related genes could be important for the dissection of their complex genetic structure. In addition, site heterogeneity was observed for MPP7, with a larger effect on spine than hip BMD. This supported the previous hypothesis of site-specific regulation of BMD, as well as shared common genetic factors. It is well known that bone property differs between spine and hip, with the spine comprises mostly trabecular bone, and hip has 50% cortical and 50% trabecular bone. Similar to other susceptible alleles of osteoporosis, the allelic variance of rs4317882 explained only a small portion ( 0.5%) of the variance in BMD at LS, but the information from this study adds to the understanding of the genetic control of BMD.
To detect the functional influence of the MPP7 gene on BMD, our in vivo study in zebrafish showed that vertebral BMD was significantly lower in the mpp7 knock-down model compared with the wild-type. Consistent with a previous study of mpp7 in a zebrafish model, our study observed an evidently higher percentage of humpback phenotype in the mpp7 knock-down zebrafish. Konig et al. (9) demonstrated that mutations of the mpp7 gene in zebrafish can affect the body shape of larvae and results in malformed and ankylotic vertebrae in adult fish. Interestingly, the MPP7 gene was recently identified as a candidate gene for human ophthalmo-acromelic syndrome (OAS, OMIM %206920) with clinical anophthalmia, vertebral anomalies, short femur or tibia, and fusion of the metacarpals (17) . MPP7 gene encodes the member 7 of the p55 Stardust family of membrane-associated guanylate kinase (MAGUK) proteins. MAGUKs are important adaptors involved in the assembly of protein complexes at sites of cell -cell contact. They are found in synapses, adherens junctions and tight junctions (18) . Data from the zebrafish study of Konig et al. also suggested that the mpp7 gene is an important factor in regulating the movements and changes that sclerotomal cells undergo during the process of osteogenesis. A loss of zebrafish mpp7 function could therefore lead to a disturbance of cell adhesion in ossification centers. Our in vivo study further illustrated the significant relationship between the mpp7 expression level and bone mass in zebrafish with mpp7 knock-down who had much lower vertebral BMD. In vitro, we observed the constitutive expression of the MPP7 gene in human HBDCs during osteogenesis and the location of Mpp7 protein in the plasma membrane and intracytoplasmic compartment of murine osteoblasts. The findings support that MPP7 affects the function of osteoblasts and osteogenesis. In addition, to detect the potential function of an identified variant in the MPP7 gene, we documented a significant relationship between genotype and MPP7 expression in human PBMCs where homozygous carriers of the risk allele 'A' of rs4317882 had two-fold lower MPP7 expression. An EMSA assay also demonstrated the binding of the GATA2 transcription factor to the risk allele 'A' but not the 'G' allele of rs4317882. The GATA2 protein belongs to a family of Zinc Finger transcription factors, critical in differentiation of vertebral development (19, 20) . GATA2 is expressed in the osteoblasts and is a regulator involved in osteogenesis (21) . The up-regulation of GATA2 expression is required for diverting preadipocytes as well as multipotent mesenchymal precursors away from adipogenesis and toward osteogenesis (22) . The present in vivo/in vitro observations together with our genetic association data with spine BMD strongly suggest that the MPP7 gene is important in the regulation of bone metabolism. Further replication and functional analyses are required to confirm this hypothesis.
Our present study has identified MPP7 as a susceptibility gene for osteoporosis. First, the association of MPP7 with BMD was successfully replicated in three independent cohorts with different sampling and genotyping methods, which strongly supported the suggestive finding identified in our previous GWAS. Secondly, the association of rs4317882 in the MPP7 gene with BMD variation reached the genomewide significance in the meta-analysis. Thirdly, we determined the functional role of MPP7 in osteoblast biology with both an in vivo animal model and in vitro cellular studies. There were, nonetheless, limitations to this study. The genetic association findings in this study could be limited to the Chinese population and further studies in other ethnic groups are necessary. This study could provide more information for the understanding of ethnic differences of genetic determination of osteoporosis. For the in vivo study, only transient knock-down experiments were done and further stable knock-out studies are necessary to unravel the mechanisms whereby MPP7 affects bone biology. The in vitro EMSA result will need to be further confirmed using chromatin immunoprecipitation assay and luciferase reporter assay.
In conclusion, this study strongly suggests an association between the MPP7 gene (10p12.1) and BMD variation with a site-specific effect at the LS. Evidence from genetic association study together with the functional data obtained from in vivo zebrafish model and in vitro cellular studies suggest that MPP7 is a susceptibility gene for osteoporosis and involved in osteogenesis and bone formation. This study provides new insights into the complex genetic architecture of osteoporosis. The identified loci and variants warrant further biological and clinical investigation.
MATERIALS AND METHODS
Subjects
HKSC discovery cohort (n ¼ 800): Subjects with extreme high or low BMD were identified from the prospective Hong Kong Osteoporosis Study (.9000 Southern Han Chinese volunteers) of the University of Hong Kong. BMD (g/cm 2 ) at LS and FN was measured by dual-energy X-ray absorptiometry (DXA; Hologic QDR 4500 plus, Hologic, Waltham, MA, USA) with standard protocol. The in vivo precision of the machine was 1.2 and 1.5% for LS and FN BMD, respectively. The age-corrected and standardized BMD (mean 0, SD 1) was generated for each gender. The low BMD subjects were those with BMD Z-score ≤ 21.28 at either LS or FN (the lowest 10% of the total cohort). High BMD subjects were those with a BMD Z-score ≥+1.0 at either of the two skeletal sites. The discovery subjects were genotyped using the Infinium Assay (Illumina, USA) with human610-quad chip, including 564 214 SNPs. After the quality control checks, a total of 785 individuals and 488 853 SNPs were retained for analysis. The subject-recruitment procedure, exclusion criteria and BMD measurement, as well as the GWAS genotyping, SNP and sample exclusion procedures have been detailed elsewhere (4).
Three northern Chinese replication samples: Three cohorts, i.e. two in Shanghai (SH1 with 985 females; SH2 with 613 males) and one in Beijing (BJ3 with 1086 females), were population-based samples recruited for genetic study of osteoporosis. Northern Chinese of age .20 years were recruited by flyers and posters from three osteoporosis centers independently. All studied subjects were local residents and Chinese of Han origin. Patients with chronic diseases and conditions that might potentially affect bone mass and bone metabolism were excluded using the same exclusion criteria as the HKSC population (4). The DXA machine was used to measure BMD through LS and FN using standard protocols, i.e. the GE-Lunar Prodigy for SH1 and SH2, the GE-Lunar Prodigy and DPX for BJ3. The in vivo precision of the machine in each centre varied from 1.1 to 1.4% and from 1.5 to 2.2% for LS and FN BMD, respectively. For each cohort, the age-corrected and standardized BMD (mean 0, SD 1) were generated for each gender. This was the same method used in our discovery and first-step replication studies. These three replication cohorts were genotyped with the TaqMan system (Applied Biosystems, USA). All subjects gave informed consent, and the study protocols were reviewed and approved by local institutional review boards.
Imputation
Imputation of untyped variants was performed using the IMPUTE program to achieve a more comprehensive coverage of the studied genomic region (23) . The HapMap Phase II R22 Asian data, i.e. Chinese Han from Beijing (CHB) and Japanese in Tokyo (JPT), were used as the reference panel in the initial analysis. Recently, with the phase I interim release of 1000 Genome project (7), further fine mapping with denser variants was conducted using its Asian database, i.e. CHB, Han Chinese South (CHS) and JPT. The genotyped SNPs with high call rate (≥95%), minor allele frequency (MAF) ≥ 1% and Hardy -Weinberg equilibrium P-value ≥ 1 × 10 26 were included for imputation. The SNPs with an imputation quality score (proper_info) ≥0.4 were used for subsequent analysis. The association analysis of each SNP was conducted using the linear regression test under the additive allele-dose model. The association with BMD at the LS and FN were tested. The conditional analysis was conducted to test whether there are multiple, independently associated signals that might represent independent causal variants in the gene.
Replication analysis
The identified top variant of each independent signal in the gene was then used for the validation in three independent northern Chinese samples. An SNP with one-sided P-value ≤0.05 and with the same direction of effect with the discovery cohort was taken as a successful replication. The association of SNP with BMD variation in the replication cohort was detected by the linear regression analysis under the additive model. The meta-analysis was conducted using the inversevariance meta-analysis approach.
Effects estimation
In our case, the coefficient of BMD on genotype from the standard linear regression may be biased due to extreme sampling of individuals for genotyping in the HKSC extreme cohort. To overcome this, we applied the DeMets -Halperin formula (24, 25) to compute an unbiased estimator, given by 
Sequencing
To identify whether there are other functional SNPs, we sequenced the coding region (+500 bp) of the identified gene in 25 high-BMD subjects who carried the protective allele of identified SNPs and 25 low-BMD subjects who carried the risk allele. The two groups were all female and matched for age (P . 0.5).
Knockout model with zebrafish and morpholinos
Wild-type (wt) zebrafish (Danio rerio) were obtained from a local aquarium and maintained and raised under standard conditions at 288C. Anti-sense morpholinos (MOs) targeting the splice junction of mpp7 and a random sequence MO for setting up control were used (Gene-Tools, USA) (Supplementary Material, Table S4 ). Procedures for micro-injection have been described previously (26) . The embryos could tolerate up to 6 ng without significant embryonic toxicity and this dose was injected throughout the study. The mpp7 knock-down embryos were termed mpp7
MO .
Cloning of mpp7 mRNA for rescue assay
To demonstrate the specificity of bone development phenotypes in mpp7 MO embryos, we co-injected 50 pg full-length mpp7 mRNA (not targetable by the mpp7 MO) with mpp7 MO at one cell stage in the rescue assay. The entire coding sequence of mpp7 was amplified by PCR from cDNA of 72 hpf embryos (Supplementary Material, Table S4 ). PCR products were TA-cloned using pGEM-T Easy Vector Systems (Promega, USA). To generate mRNA, the mpp7 clone was linearized by digestion with SalI (Invitrogen, USA) and in vitro transcribed using the T7 mMessage mMachine Kit (Ambion, USA). To increase stability, the mRNA was polyadenylated with the Poly (A) Tailing Kit (Ambion, USA). The size and integrity of the synthesized mRNA was confirmed by RNA formaldehyde gel electrophoresis. The percentage of humpback phenotype for each group, i.e. wt, mpp7
MO and rescued (mpp7 MO + mpp7 mRNA) group, at 24 hpf was counted.
Quantification of bone density in developing vertebrae
To quantify the bone mass in developing vertebrae, zebrafish embryos of the wt, mpp7
MO and rescued groups at 14 day-post-fertilization (dpf) were used for bone staining with alizarin red. Embryos were first fixed in 4% paraformaldehyde (PFA) and then labeled with alizarin red (27) . Embryos were stored in glycerin after staining. Bright-field images were taken under Nikon SMZ800 (Nikon Corporation, Kawasaki, Japan) and P-Plan 1× objective in 3% methylcellulose with Nikon Digital Sight DSL2 (Nikon Hong Kong Ltd., Hong Kong). Fluorescent images were taken under Olympus IX70 (Olympus Corporation, Japan) and 10×/0.3 NA objective in 3% methylcellulose, with Olympus DP71 (Olympus Corporation, Japan) and Olympus DP-BSW basic Software at 1.0-s exposure time. Fluorescent intensity of vertebra 3, 4 and 5 in each embryo were quantified by ImageJ (v1.43u). The study was approved by the Committee of the Use of Laboratory and Research Animals (CULATR) in the University of Hong Kong.
Expression of mRNA in human cells
Expression of the gene was studied in human HBDCs and human PBMCs using semi-quantitative PCR (RT-PCR) and/ or qRT-PCR, respectively. Human PBMCs were isolated using a standard protocol (4) . HBDCs from healthy subjects were generated as described previously (4, 28) . The isolated adherent HBDCs were harvested for mRNA extraction. HBDCs were seeded at 0.05 M/ml in 6-well plates and grown in alpha-MEM with 10% fetal bovine serum (FBS) until 90% confluence. Osteogenesis of HBDCs was induced by osteogenic medium (100 mM L-ascorbic acid, 10 mM betaglycerophosphate in alpha-MEM with 10% FBS). HBDCs were collected at Days 0, 3, 7, 14 and 21. Total RNA of PBMCs and HBDCs was extracted using Trizol w reagent according to the manufacturer's instructions (Invitrogen, CA). For cDNA synthesis by M-MLV Reverse Transcriptase according to the manufacturer's protocol, 0.5 mg of RNA was used (Invitrogen, CA).
MPP7 gene expression in human HBDCs with RT-PCR was tested using primers 5 ′ -TTATACCCGGCAGCAAAGAG-3 ′ and 5 ′ -TGAGGCTGAACATCCAACAA-3 ′ with annealing temperature at 588C. Results were normalized to GAPDH gene expression by using primers 5
′ -GCCTCCTGCAC CACCACC-3 ′ and 5 ′ -CCGTTCAGCTCAGGGATGA-3 ′ with annealing temperature at 588C. The qRT-PCR for HBDCs and PBMC samples was performed using the Taqman w one-step PCR master mix kit with gene-specific target primers and FAM probes of MPP7 (ABI gene expression assay Hs00399584_m1). Each sample was simultaneously quantified using eukaryotic 18S primers and target probes (ABI gene expression assay 4319413E). Amplification was performed in an ABI Prism 7000 sequence detector, using standard settings of 40 cycles with an annealing temperature of 608C. All samples were assayed in triplicate.
Immunofluorescence microscopy
Immunostaining was performed in murine MC3T3-E1 osteoblast cells (subclone 4, ATCC) grown on Collagen type I-coated culture slides (Cat # 354630, BD Biosciences, USA). Cells were fixed with 2% PFA for 15 min at room temperature. After washing with phosphate-buffered saline (PBS), they were kept at 48C, ready for staining. Blocking for nonspecific binding for 2 h at 48C and subsequent incubation of primary and secondary antibodies were done in PBS containing 5% BSA. Incubation of primary and secondary antibodies was at 48C overnight and for 2 h at room temperature respectively. Negative control was performed in the absence of anti-MPP7 antibody. The primary antibody used was a rabbit polyclonal, affinity-purified MPP7 antibody (1:100, Cat #12983-1-AP, Proteintech, Inc., USA). Secondary antibody was a goat anti-rabbit IgG conjugated to Alexa 594 (1:500, Cat #A11012, Molecular Probes, USA). After staining, slides were mounted with ProLong Gold antifade mounting medium (Cat #P36934, Invitrogen). Images were collected with a Carl Zeiss LSM710 confocal microscope and analyzed by ZEN 2009 v5.5 SP1 software (Zeiss, Germany).
Electrophoretic mobility shift assay
